Wikisage, the free encyclopedia of the second generation, is digital heritage
Cannabis (drug): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Managing drug-resistant epilepsy: challenges and solutions) |
||
| Line 1: | Line 1: | ||
<small>unknown efficacy in [[epilepsy]] </small> | <small>unknown efficacy in [[epilepsy]] </small> | ||
<ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/pdf/ndt-12-2605.pdf]</ref> | <ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/pdf/ndt-12-2605.pdf Managing drug-resistant epilepsy: challenges and solutions]</ref> | ||
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/26941559 Is the medical use of cannabis a therapeutic option for children?]</ref> | <ref>[https://www.ncbi.nlm.nih.gov/pubmed/26941559 Is the medical use of cannabis a therapeutic option for children?]</ref> | ||
Revision as of 18:39, 23 December 2016
unknown efficacy in epilepsy [1] [2]
The Cannabis sativa plant contains([3]) more than 400 compounds, of which 100 are known as phytocannabinoids. The two cannabinoids with the highest concentrations in cannabis are delta9-tetrahydrocannabinol (Δ9-THC), responsible for most of the psychotomimetic effects of the drug, and cannabidiol (CBD), the most common non-psychoactive cannabinoid [4]
Links
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
Medical Cannabis
Kolikonda et al. 2016 [5]
Entourage effect
Ben Shabat et al 1998. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur J Pharmacol.
- ↑ Managing drug-resistant epilepsy: challenges and solutions
- ↑ Is the medical use of cannabis a therapeutic option for children?
- ↑ http://www.agriculture.pa.gov/Protect/PlantIndustry/NIPPP/Documents/marijuana%20article.pdf
- ↑ Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
- ↑ Medical Cannabis for epilepsy Innovations clin.neurosci 13(3-4):